Cerbo Expands AI Scribe to Virtual Visits - Nov 3

The Story

Cerbo announced on Nov. 3 that its AI Scribe now drafts the structured note inside the chart for Cerbo Telemedicine and Zoom visits, so telehealth no longer means extra time on documentation. The update brings native AI charting to virtual visits and targets clinicians using Cerbo's EHR for cash-pay, personalized care.

Why It Matters For Your Portfolio

• Product Expansion, Nov. 3, 2026: The company expanded AI Scribe to cover Cerbo Telemedicine and Zoom visits, a direct product upgrade that could drive adoption among Cerbo users.
• Operational Efficiency: The AI Scribe drafts structured notes inside the chart, which the company says reduces documentation time, potentially improving clinician throughput and platform stickiness; Cerbo did not disclose quantified time savings or revenue impact.
• Market Reach: Native AI charting for virtual visits ties Cerbo directly to telehealth workflows, including Zoom-based visits, making the platform more competitive in telemedicine ecosystems and relevant to investors watching telehealth tools such as Zoom Video Communications (ZM).

The Trade

Growth and digital-health investors should note this product-level catalyst as a potential adoption driver, while more conservative investors may want to wait for usage and revenue metrics. Watch for follow-up announcements on customer adoption, pricing, and any disclosed productivity metrics to gauge commercial impact; Cerbo has not published financial or usage numbers with this release. Do you want to track uptake? Monitor company updates and user case studies for measurable results.

This piece is informational and not investment advice.